Mapping the Pareto optimal design space for a functionally deimmunized biotherapeutic candidate.
The immunogenicity of biotherapeutics can bottleneck development pipelines and poses a barrier to widespread clinical application. As a result, there is a growing need for improved deimmunization technologies. We have recently described algorithms that simultaneously optimize proteins for both reduc...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC4288714?pdf=render |